Skip to main content
SpringerLink
Log in

Pharmacological Management of People Living with End-Stage Chronic Obstructive Pulmonary Disease

  • Therapy in Practice
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Abstract

Supportive care and pharmacological treatment can improve the quality of life of people with end-stage chronic obstructive pulmonary disease (COPD) who cope on a daily basis with substantial physical, psychological, social and spiritual morbidity. Smoking cessation is the only intervention that reduces the rate of progression of COPD, but evidence-based drug treatments and non-pharmacological strategies can relieve symptoms and reduce the impact of exacerbations. People with severe COPD live with increasingly troublesome breathlessness and other symptoms such as fatigue, pain, sputum production and weight loss. As breathlessness increases, treatment is stepped up from short-acting to long-acting bronchodilators supplemented by non-pharmacological interventions such as pulmonary rehabilitation. Opiates relieve breathlessness, and referral to a multidisciplinary breathlessness service is an option for those with intractable symptoms. Other smoking-related conditions, such as coronary heart disease and lung cancer as well as depression and anxiety are common and should be treated with conventional pharmacotherapy. Acute exacerbations become more frequent and more severe as the disease reaches end-stage. Inhaled corticosteroids in combination with long-acting bronchodilators can reduce the frequency of exacerbations, and supported self-management aims to facilitate timely treatment of deterioration. Palliative care services have traditionally been predicated on identifying people with end-stage disease—a model that does not resonate with the unpredictable, relapsing trajectory of COPD. Approaches to care that promote a flexible approach to palliation alongside curative care could do much to improve the burden of living with severe COPD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Adapted with permission from Lynn and Adamson [19] and Lanken et al. [28]

Figure 2

Adapted from Rocker et al. [8]

Similar content being viewed by others

References

  1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2016). http://www.goldcopd.org. Accessed Oct 2016.

  2. Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009;374:733–43.

    Article  PubMed  Google Scholar 

  3. van Gemert F, Kirenga B, Chavannes N, Kamya M, Luzige S, Musinguzi P, et al. Prevalence of chronic obstructive pulmonary disease and associated risk factors in Uganda (FRESH AIR Uganda): a prospective cross-sectional observational study. Lancet Global Health. 2015;3:e44–51.

    Article  PubMed  Google Scholar 

  4. van Gemert F, Chavannes N, Kirenga B, Jones R, Williams S, Tsiligianni I, et al. Socio-economic factors, gender and smoking as determinants of COPD in a low-income country of sub-Saharan Africa: FRESH AIR Uganda. NPJ Prim Care Respir Med. 2016;26:16050.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2197–223.

    Article  PubMed  Google Scholar 

  6. Habraken JM, Willems DL, de Kort SJ, Bindels PJE. Health care needs in end-stage COPD: a structured literature review. Patient Educ Couns. 2007;68:121–30.

    Article  PubMed  Google Scholar 

  7. Seamark DA, Seamark CJ, Halpin D. Palliative care in chronic obstructive pulmonary disease: a review for clinicians. J R Soc Med. 2007;100:225–33.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Rocker GM, Sinuff T, Horton R, Hernandez P. Advanced chronic obstructive pulmonary disease: innovative approaches to palliation. J Palliat Med. 2007;10:783–96.

    Article  PubMed  Google Scholar 

  9. Janssen DJ, Spruit MA, Wouters EF, Schols JM. Daily symptom burden in end-stage chronic organ failure: a systematic review. Palliat Med. 2008;22:938–48.

    Article  CAS  PubMed  Google Scholar 

  10. Giacomini M, DeJean D, Simeonov D, Smith A. Experiences of living and dying with COPD: a systematic review and synthesis of the qualitative empirical literature. Ont Health Technol Assess Ser. 2012;12:1–47.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Buckingham S, Kendall M, Ferguson S, MacNee W, Sheikh A, White P, et al. HELPing older people with very severe chronic obstructive pulmonary disease (HELP-COPD): piloting a practical intervention. NPJ Prim Care Respir Med. 2015;25:15020.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Epiphaniou E, Shipman C, Harding R, Mason B, Murray SA, Higginson IJ, et al. Coordination of end-of-life care for patients with lung cancer and those with advanced COPD: are there transferable lessons? A longitudinal qualitative study. Prim Care Respir J. 2014;23:46–51.

    Article  PubMed  Google Scholar 

  13. Gore JM, Brophy CJ, Greenstone MA. How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax. 2000;55:1000–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380:37–43.

    Article  PubMed  Google Scholar 

  15. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:37–43.

    Article  Google Scholar 

  16. Connors AF, Dawson NV, Thomas C, Harrell FE, Desbiens N, Fulkerson WJ, et al. Outcomes following acute exacerbation of chronic obstructive lung disease. The SUPPORT investigators. Am J Respir Crit Care Med. 1996;154:959–67.

    Article  PubMed  Google Scholar 

  17. Almagro P, Calbo E, de Echagüen AO, Quintana BBS, Heredia JL, Garau J. Mortality after hospitalization for COPD. Chest. 2002;121:1441–8.

    Article  PubMed  Google Scholar 

  18. Calverley PMA, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;356:775–89.

    Article  CAS  PubMed  Google Scholar 

  19. Lynn J, Adamson D. Living well at the end of life. Adapting health care to serious chronic illness in old age. Santa Monica: RAND; 2003.

    Google Scholar 

  20. World Health Organization Europe. The solid facts: palliative care. Copenhagen: WHO; 2004.

    Google Scholar 

  21. House of Commons Health Committee. Palliative care. London: The Stationery Office; 2004.

    Google Scholar 

  22. National Institute for Health and Clinical Excellence. National clinical guideline management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax. 2004;59(Suppl 1):S1–232.

    Google Scholar 

  23. Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, Van der Molen T, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011;155:179–91.

    Article  PubMed  Google Scholar 

  24. Abramson M, Frith P, Yang I, McDonald C, Hancock K, Jenkins S, et al. COPD-X concise guide for primary care. Brisbane: Lung Foundation Australia; 2016.

    Google Scholar 

  25. Kendall M, Buckingham S, Ferguson S, Hewitt N, Pinnock H. We need to stop looking for something that is not there…. [letter]. NPJ Prim Care Respir Med. 2014;24:14031.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Murray SA, Kendall M, Boyd K, Sheikh A. Illness trajectories and palliative care. BMJ. 2005;330:1007–11.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Murray SA, Boyd K, Sheikh A. Palliative care in chronic illness. We need to move from prognostic paralysis to active total care. BMJ. 2005;330:611–2.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Lanken PN, Terry PB, DeLisser HM, Fahy BF, Hansen-Flaschen J, Heffner JE, on behalf of the ATS End-of-Life Care Task Force, et al. An Official American Thoracic Society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses. Am J Respir Crit Care Med. 2008;177:912–27.

    Article  PubMed  Google Scholar 

  29. Christakis NA, Lamont EB. Extent and determinants of error in doctor’s prognosis in terminally ill patients: prospective cohort study. BMJ. 2000;320:469–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Pinnock H, Kendall M, Murray SA, Worth A, Levack P, Porter M, et al. Living and dying with severe chronic obstructive pulmonary disease: multi-perspective longitudinal qualitative study. BMJ. 2011;342:d142.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Coventry PA, Grande GE, Richards DA, Todd CJ. Prediction of appropriate timing of palliative care for older adults with non-malignant life-threatening disease: a systematic review. Age Ageing. 2005;34:218–27.

    Article  PubMed  Google Scholar 

  32. Murray S, Pinnock H, Sheikh A. Palliative care for people with COPD: we need to meet the challenge. Prim Care Respir J. 2006;15:362–4.

    Article  PubMed  Google Scholar 

  33. Habraken JM, Pols J, Bindels PJE, Willems DL. The silence of patients with end-stage COPD: a qualitative study. Br J Gen Pract. 2008;58:844–9.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Kendall M, Buckingham S, Ferguson S, MacNee W, Sheikh A, White P, et al. Exploring the concept of need in people with very severe chronic obstructive pulmonary disease: a qualitative study BMJ Support Palliat Care. 2015. doi:10.1136/bmjspcare-2015-000904.

  35. Tashkin DP, Rennard S, Hays JT, Lawrence D, Marton JP, Lee TC. Lung function and respiratory symptoms in a 1-year randomised smoking cessation trial of varenicline in COPD patients. Respir Med. 2011;105:1682–90.

    Article  CAS  PubMed  Google Scholar 

  36. Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA. 1994;272:1497–505.

    Article  CAS  PubMed  Google Scholar 

  37. Stead LF, Koilpillai P, Fanshawe TR, Lancaster T. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev. 2016;3:CD008286. doi:10.1002/14651858.CD008286.pub3.

    PubMed  Google Scholar 

  38. van Eerd EAM, van der Meer RM, van Schayck OCP, Kotz D. Smoking cessation for people with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2016;8:CD010744. doi:10.1002/14651858.CD010744.pub2.

    Google Scholar 

  39. Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev. 2013;5:CD009329. doi:10.1002/14651858.CD009329.pub2.

    Google Scholar 

  40. Stead LF, Perera R, Bullen C, Mant D, Hartmann-Boyce J, Cahill K, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2012;11:CD000146. doi:10.1002/14651858.CD000146.pub4.

    PubMed  Google Scholar 

  41. Rigotti NA, Clair C, Munafò MR, Stead LF. Interventions for smoking cessation in hospitalised patients. Cochrane Database Syst Rev. 2012;5:CD001837. doi:10.1002/14651858.CD001837.pub3.

    PubMed Central  Google Scholar 

  42. Cahill K, Lindson-Hawley N, Thomas KH, Fanshawe TR, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2016;5:CD006103. doi:10.1002/14651858.CD006103.pub7.

    Google Scholar 

  43. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med. 1980;93:391–8.

    Article  Google Scholar 

  44. Cooper CB, Waterhouse J, Howard P. Twelve year clinical study of patients with hypoxic cor pulmonale given long term domiciliary oxygen therapy. Thorax. 1987;42:105–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Gulbas G, Gunen H, In E, Kilic T. Long-term follow-up of chronic obstructive pulmonary disease patients on long-term oxygen treatment. Int J Clin Pract. 2012;66:152–7.

    Article  CAS  PubMed  Google Scholar 

  46. British Thoracic Society. BTS guideline for home oxygen use in adults. Thorax. 2015;70(Suppl 1):i1–43.

    Article  Google Scholar 

  47. Goodridge D. People with chronic obstructive pulmonary disease at the end of life: a review of the literature. Int J Palliat Nurs. 2006;12:390–6.

    Article  PubMed  Google Scholar 

  48. Spathis A, Booth S. End of life care in chronic obstructive pulmonary disease: in search of a good death. Int J COPD. 2008;3:11–29.

    Article  Google Scholar 

  49. Dean MM. End-of-life care for COPD patients. Prim Care Respir J. 2008;17:46–50.

    Article  PubMed  Google Scholar 

  50. Ambrosino N, Simonds A. The clinical management in extremely severe COPD. Respir Med. 2007;101:1613–24.

    Article  PubMed  Google Scholar 

  51. Elofsson LC, Ohlen J. Meanings of being old and living with chronic obstructive pulmonary disease. Palliat Med. 2004;18:611–8.

    Article  PubMed  Google Scholar 

  52. Skilbeck J, Mott L, Smith D, Page H, Clark D. Nursing care for people dying from chronic obstructive pulmonary disease. Int J Palliat Nurs. 1997;3:100–6.

    Google Scholar 

  53. Gysels M, Bausewein C, Higginson IJ. Experiences of breathlessness: a systematic review of the qualitative literature. Palliat Support Care. 2007;5:281–302.

    Article  PubMed  Google Scholar 

  54. Seamark DA, Blake SD, Seamark CJ. Living with severe chronic obstructive pulmonary disease (COPD): perceptions of patients and their carers. Palliative Med. 2004;18:619–25.

    Article  CAS  Google Scholar 

  55. Jones PW, Harding G, Wiklund I, Berry P, Leidy NI. Improving the process and outcome of care in COPD: development of a standardised assessment tool. Prim Care Respir J. 2009;18:208–15.

    Article  PubMed  Google Scholar 

  56. Sestini P, Renzoni E, Robinson S, Poole P, Ram FSF. Short-acting beta2-agonists for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2002. doi:10.1002/14651858.CD001495.

    PubMed  Google Scholar 

  57. Appleton S, Jones T, Poole P, Pilotto L, Adams R, Lasserson TJ, et al. Ipratropium bromide versus short acting beta-2 agonists for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006. doi:10.1002/14651858.CD001387.pub2.

    Google Scholar 

  58. Kew KM, Mavergames C, Walters JA. Long-acting beta2-agonists for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2013;10:CD010177. doi:10.1002/14651858.CD010177.pub2.

    Google Scholar 

  59. Barr RG, Bourbeau J, Camargo CA Jr. Tiotropium for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2005;2:CD002876. doi:10.1002/14651858.CD002876.pub2.

    Google Scholar 

  60. Farne HA, Cates CJ. Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015. doi:10.1002/14651858.CD008989.pub3.

    PubMed  Google Scholar 

  61. Van Boven JF, Chavannes NH, van der Molen T, Rutten-van Mölken MP, Postma MJ, Vegter S. Clinical and economic impact of non-adherence in COPD: a systematic review. Respir Med. 2014;108:103–13.

    Article  PubMed  Google Scholar 

  62. Nannini LJ, Poole P, Milan SJ, Holmes R, Normansell R. Combined corticosteroid and long-acting beta2-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2013. doi:10.1002/14651858.CD003794.pub4.

    Google Scholar 

  63. Kew KM, Seniukovich A. Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2014. doi:10.1002/14651858.CD010115.pub2.

    Google Scholar 

  64. Rojas-Reyes MX, García Morales OM, Dennis RJ, Karner C. Combination inhaled steroid and long-acting beta2-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2016. doi:10.1002/14651858.CD008532.pub3.

    Google Scholar 

  65. Corhay J-L, Nguyen Dang D, Van Cauwenberge H, Louis R. Pulmonary rehabilitation and COPD: providing patients a good environment for optimising therapy. Int J Chron Obstruct Pulmon Dis. 2014;9:27–39.

    PubMed  Google Scholar 

  66. McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015. doi:10.1002/14651858.CD003793.pub3.

    Google Scholar 

  67. Evans RA, Singh SJ, Collier R, Williams JE, Morgan MD. Pulmonary rehabilitation is successful for COPD irrespective of MRC dyspnoea grade. Respir Med. 2009;103:1070–5.

    Article  CAS  PubMed  Google Scholar 

  68. Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188:e13–64.

    Article  PubMed  Google Scholar 

  69. Murphy L, Harrington P, Taylor SJC, Teljour C, Smith SM, Pinnock H, et al. The clinical-effectiveness of self-management support interventions in chronic obstructive pulmonary disease: an overview of reviews. Chron Respir Dis (in press).

  70. Lewis A, Cave P, Stern M, Welch L, Taylor K, Russell J, et al. Singing for Lung Health—a systematic review of the literature and consensus statement. NPJ Prim Care Respir Med. 2016;1(26):16080.

    Article  Google Scholar 

  71. Jennings AL, Davies AN, Higgins JP, Gibbs JS, Broadley KE. A systematic review of the use of opioids in the management of dyspnoea. Thorax. 2002;57:939–44.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Abernethy AP, Currow DC, Frith P, Fazekas BS, McHugh A, Bui C. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ. 2003;327:523–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. British Medical Association/Royal Pharmaceutical Society. British National Formulary. No. 72. London: British Medical Association/Royal Pharmaceutical Society; 2016. p. 421.

  74. Hardy J, Randall C, Pinkerton E, Flatley C, Gibbons K, Allan S. A randomised, double-blind controlled trial of intranasal midazolam for the palliation of dyspnoea in patients with life-limiting disease. Support Care Cancer. 2016;24:3069–76.

    PubMed  Google Scholar 

  75. Simon ST, Higginson IJ, Booth S, Harding R, Bausewein C. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database Syst Rev. 2010. doi:10.1002/14651858.CD007354.pub2.

    PubMed  Google Scholar 

  76. Johnson MJ, Barbetta C, Currow DC, Maddocks M, McDonald V, Mahadeva R, et al. Management of chronic breathlessness. In: Bausewein C, Currow DC, Johnson MJ, editors. Palliative care in respiratory disease. ERS Monograph, vol. 73. Sheffield: European Respiratory Society; 2016. p. 111–33.

    Google Scholar 

  77. Currow DC, Agar M, Smith J, Abernethy AP. Does palliative home oxygen improve dyspnoea? A consecutive cohort study. Palliative Med. 2009;23:309–16.

    Article  CAS  Google Scholar 

  78. Booth S, Anderson H, Swannick M, Wade R, Kite S, Johnson M. The use of oxygen in the palliation of breathlessness. A report of the expert working group of the scientific committee of the association of palliative medicine. Respir Med. 2004;98:66–77.

    Article  PubMed  Google Scholar 

  79. Struik FM, Lacasse Y, Goldstein RS, Kerstjens HA, Wijkstra PJ. Nocturnal noninvasive positive pressure ventilation in stable COPD: a systematic review and individual patient data meta-analysis. Respir Med. 2014;108:329–37.

    Article  CAS  PubMed  Google Scholar 

  80. Higginson IJ, Bausewein C, Reilly CC, Gao W, Gysels M, Dzingina M, et al. An integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness: a randomised controlled trial. Lancet Respir Med. 2014;2:979–87.

    Article  PubMed  Google Scholar 

  81. HajGhanbari B, Holsti L, Road JD, Reid WD. Pain in people with chronic obstructive pulmonary disease. Resp Med. 2012;106:998–1005.

    Article  Google Scholar 

  82. World Health Organization. WHO's cancer pain ladder for adults. http://www.who.int/cancer/palliative/painladder/en. Accessed Oct 2016.

  83. Ferreira I, Brooks D, Lacasse Y, Goldstein R, White J. Nutritional supplementation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2005. doi:10.1002/14651858.CD000998.pub.

    Google Scholar 

  84. Osadnik CR, McDonald CF, Jones AP, Holland AE. Airway clearance techniques for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2012. doi:10.1002/14651858.CD008328.pub2.

    PubMed  Google Scholar 

  85. Poole P, Chong J, Cates CJ. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015. doi:10.1002/14651858.CD001287.pub5.

    Google Scholar 

  86. National Institute for Health and Clinical Excellence. Multimorbidity: clinical assessment and management. NICE guidance 56. https://www.nice.org.uk/guidance/ng56. Accessed Dec 2016.

  87. Feinstein AR. The pre-therapeutic classification of co-morbidity in chronic disease. J Chronic Dis. 1970;23:455–68.

    Article  CAS  PubMed  Google Scholar 

  88. Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46:72–83.

    Article  CAS  PubMed  Google Scholar 

  89. O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44:213–8.

    Article  PubMed  Google Scholar 

  90. Van Manen JG, Bindels PJE, Dekker FW, IJzermans CJ, Van der Zee JS, Schade E. Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax. 2002;57:412–6.

    Article  PubMed  PubMed Central  Google Scholar 

  91. Mikkelsen RL, Middelboe T, Pisinger C, Stage KB. Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review. Nord J Psychiatry. 2004;58:65–70.

    Article  PubMed  Google Scholar 

  92. Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik ME, Yohannes AM, et al. Anxiety and depression in COPD. Current understanding, unanswered questions and research needs. Chest. 2008;134:435–565.

    Article  Google Scholar 

  93. Brenes G. Anxiety and chronic pulmonary obstructive disease: prevalence, impact and treatment. Psychosom Med. 2003;65:963–70.

    Article  PubMed  Google Scholar 

  94. Fan VS, Ramsey SD, Giardino ND, Make BJ, Emery CF, Diaz PT, et al. Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease. Arch Intern Med. 2007;167:2345–53.

    Article  PubMed  Google Scholar 

  95. Usmani ZA, Carson KV, Cheng JN, Esterman AJ, Smith BJ. Pharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2011. doi:10.1002/14651858.CD008483.pub2.

    PubMed  Google Scholar 

  96. Yohannes AM, Alexopoulos GS. Pharmacological treatment of depression in older patients with chronic obstructive pulmonary disease: impact on the course of the disease and health outcomes. Drugs Aging. 2014;31:483.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Tselebis A, Pachi A, Ilias I, Kosmas E, Bratis D, Moussas G, et al. Strategies to improve anxiety and depression in patients with COPD: a mental health perspective. Neuropsychiatr Dis Treat. 2016;12:297.

    Article  PubMed  PubMed Central  Google Scholar 

  98. Baraniak A, Sheffield D. The efficacy of psychologically based interventions to improve anxiety, depression and quality of life in COPD: a systematic review and meta-analysis. Patient Educ Couns. 2011;83:29–36.

    Article  PubMed  Google Scholar 

  99. Heslop K, Newton J, Baker C, Burns G, Carrick-Sen D, De Soyza A. Effectiveness of cognitive behavioural therapy (CBT) interventions for anxiety in patients with chronic obstructive pulmonary disease (COPD) undertaken by respiratory nurses: the COPD CBT CARE study: (ISRCTN55206395). BMC Pulm Med. 2013;13:62.

    Article  PubMed  PubMed Central  Google Scholar 

  100. Coventry PA, Bower P, Keyworth C, Kenning C, Knopp J, Garrett C, et al. The effect of complex interventions on depression and anxiety in chronic obstructive pulmonary disease: systematic review and meta-analysis. PLoS One. 2013;8:e60532.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  101. Guthrie E, Palmer L, Lelliott P, Agulnik D, Dupin M. No health without mental health – the supporting evidence. London: Royal College of Psychiatrists, Academy of Medical Royal Colleges; 2010.

    Google Scholar 

  102. Global Initiative for Asthma and Global Initiative for Chronic Obstructive Lung Disease. Asthma, COPD and Asthma-COPD Overlap Syndrome (ACOS). 2015. http://ginasthma.org/asthma-copd-and-asthma-copd-overlap-syndrome-acos. Accessed Oct 2016.

  103. Suissa S, Dell’Aniello S. Ernst P Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax. 2012;67:957–63.

    Article  PubMed  PubMed Central  Google Scholar 

  104. Calverley PM, Rabe KF, Goehring UM, Kristiansen S, Fabbri LM, Martinez FJ. Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials. Lancet. 2009;374:685–94.

    Article  CAS  PubMed  Google Scholar 

  105. Rabe KF. Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary disease. Br J Pharmacol. 2011;163:53–67.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  106. Herath SC, Poole P. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD). Cochrane Database Syst Rev. 2013. doi:10.1002/14651858.CD009764.pub2.

    PubMed  Google Scholar 

  107. Varkey JB, Varkey AB, Varkey B. Prophylactic vaccinations in chronic obstructive pulmonary disease: current status. Curr Opinion Pulm Med. 2009;15:90–9.

    Article  Google Scholar 

  108. Zwerink M, Brusse-Keizer M, van der Valk PD, Zielhuis GA, Monninkhof EM, van der Palen J, et al. Self management for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2014. doi:10.1002/14651858.CD002990.pub3.

    PubMed  Google Scholar 

  109. Ure J, Hanley J, Pinnock H, Kidd G, McCall Smith E, Tarling A, et al. Piloting tele-monitoring in Chronic Obstructive Pulmonary Disease: a mixed methods exploration of issues in design and implementation. Prim Care Respir J. 2012;21:57–64.

    Article  PubMed  Google Scholar 

  110. Bolton CE, Waters CS, Peirce S, Elwyn G, on behalf of EPSRC and MRC Grand Challenge Team. Insufficient evidence of benefit: a systematic review of home telemonitoring for COPD. J Eval Clin Pract. 2011;17:1216–22.

    Article  PubMed  Google Scholar 

  111. Steventon A, Bardsley M, Billings J, Dixon J, Doll H, Hirani S, for the Whole System Demonstrator Evaluation Team, et al. Effect of telehealth on use of secondary care and mortality: findings from the Whole System Demonstrator cluster randomised trial. BMJ. 2012;344:e3874.

    Article  PubMed  PubMed Central  Google Scholar 

  112. Pinnock H, Hanley J, McCloughan L, Todd A, Krishan A, Lewis S, et al. Effectiveness of telemonitoring integrated into existing clinical services on hospital admission for exacerbation of chronic obstructive pulmonary disease: researcher blind, multicentre, randomised controlled trial. BMJ. 2013;347:f6070.

    Article  PubMed  PubMed Central  Google Scholar 

  113. Ek K, Ternestedt B-M. Living with chronic obstructive pulmonary disease at the end of life: a phenomenological study. J Adv Nurs. 2008;62:470–8.

    Article  PubMed  Google Scholar 

  114. Steinhauser KE, Voils CI, Clipp EC, Bosworth HB, Christakis NA, Tulsky JA. Are you at peace? One item to probe spiritual concerns at the end of life. Arch Intern Med. 2006;166:101–5.

    Article  PubMed  Google Scholar 

  115. Curtis JR. Palliative and end-of-life care for patients with severe COPD. Eur Respir J. 2008;32:796–803.

    Article  CAS  PubMed  Google Scholar 

  116. Knauft E, Nielsen EL, Engelberg RA, Patrick DL, Curtis JR. Barriers and facilitators to end-of-life care communication for patients with COPD. Chest. 2005;127:2188–96.

    Article  PubMed  Google Scholar 

  117. Back AL, Arnold RM, Quill TE. Hope for the best, and prepare for the worst. Ann Intern Med. 2003;138:439–43.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Armadale Medical Practice, Armadale, West Lothian, UK

    Victoria Dalgliesh

  2. Allergy and Respiratory Research Group, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Doorway 3, Medical School, Teviot Place, Edinburgh, EH8 9AG, UK

    Hilary Pinnock

  3. Whitstable Medical Practice, Whitstable, Kent, UK

    Hilary Pinnock

Authors
  1. Victoria Dalgliesh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hilary Pinnock
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hilary Pinnock.

Ethics declarations

Conflicts of interest

VD and HP declare that they have no conflicts of interest.

Funding

No funding was received for this review.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dalgliesh, V., Pinnock, H. Pharmacological Management of People Living with End-Stage Chronic Obstructive Pulmonary Disease. Drugs Aging 34, 241–253 (2017). https://doi.org/10.1007/s40266-017-0440-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40266-017-0440-3

Keywords

Search

Navigation